Respiri Limited (RSH, formerly iSonea Limited) is a medical technology company developing devices and mobile health applications to improve the management of chronic, costly respiratory disorders .RSH's current generation technology has been cleared for use by the Australian TGA, has achieved the European Union CE-mark and is pending approval by the U.S. Food and Drug Administration (FDA).